Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label, Single Centre, Single Arm, Prospective Feasibility Study Evaluating the Effectiveness of Near-infrared Fluorescence (NIRF) Using Indo-cyanine Green (ICG) in Minimally Invasive Paediatric Oncology Surgery (MIS)

NCT04854018 is registered in ClinicalTrials.gov with Birmingham Women's and Children's NHS Foundation Trust as lead sponsor.

NCT NCT04854018
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04854018 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label, Single Centre, Single Arm, Prospective Feasibility Study Evaluating the Effectiveness of Near-infrared Fluorescence (NIRF) Using Indo-cyanine Green (ICG) in Minimally Invasive Paediatric Oncology Surgery (MIS)
Lead sponsor
Birmingham Women's and Children's NHS Foundation Trust
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2021
Completion date
September 30, 2022
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic ewing sarcoma, metastatic osteosarcoma, non-rhabdo. soft tissue sarcoma, pediatric renal tumor, pulmonary metastasis, rhabdomyosarcoma